KORU Medical Systems, Inc. (KRMD) is a leading healthtech company specializing in the production of innovative and easy-to-use, patient-friendly, at-home drug delivery systems that have significantly enhanced patient care since its inception. Founded in 1986 and headquartered in Chester, New York, the company was formerly known as REPRO Med Systems, Inc., before rebranding to KORU Medical Systems to better reflect its evolved focus on developing innovative solutions for chronic care patients.
By developing solutions that focus on the patients' comfort and healthcare providers' need for reliability, KORU Medical Systems aims to address healthtech’s most pressing challenges. Their flagship products, the FREEDOM Syringe Infusion System and the HIgH-Flo Subcutaneous Safety Needle Sets, are prime examples of the company's commitment to providing transformative and practical innovations.
The FREEDOM Syringe Infusion System is a compact, lightweight, ambulatory syringe infusion system used in therapies such as immune globulin (IG) administration. It is designed to include both a portable, battery-operated primary pump and a dedicated disposable syringe infusion set. The system boasts an electronic pump that is silent, lightweight and easy to infuse reliably, anywhere, anytime.
KORU's HIgH-Flo Subcutaneous Safety Needle Sets are optimally designed to facilitate a high flow rate for smaller gauge sizes, making the treatment phase fast and comfortable for the patient. The unique all-in-one pre-assembled package contributes to patient convenience.
The company is publicly traded on the NASDAQ under the ticker symbol KRMD. KORU Medical's recent financial reports highlighting its strong and sustained growth trajectory underscore its commitment to innovation and patient care. The company's ongoing research and dedication to creating high-end medical products indeed reflect its emphasis on improving the standard and efficiency of home healthcare.
In a nutshell, KORU Medical Systems, Inc. is a leading player in the healthtech industry. Its efforts in developing groundbreaking, patient-friendly home drug delivery systems have led to a significant change in the healthcare landscape, specifically in the realm of chronic care. It continues to pave its way forward as a leading innovator in the healthcare sector by providing reliable solutions for both patients and healthcare professionals.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
This article highlights three promising penny stocks with market caps over $90 million: KORU Medical Systems (KRMD), Tilly's (TLYS), and Crimson Wine Group (CWGL). Each company is analyzed for its financial health, growth potential, and recent performance, offering insights into their revenue generation, profitability, and balance sheet strength. The piece suggests that these smaller companies could offer valuable growth opportunities for investors willing to explore the niche penny stock market.
KORU Medical Systems (NASDAQ:KRMD) reported strong quarterly earnings, exceeding analyst estimates with an EPS of $0.01 and revenue of $12.05 million, an 18% increase year-over-year. The company achieved its first positive net income since 2019 and positive operating cash flow, though it narrowed its 2026 revenue guidance due to slower international product launches and withdrew its U.S. PHESGO 510(k) application. KORU Medical Systems is also advancing its connected-monitoring technology and Freedom 360 device, with the latter on track for U.S. clearance submission by late 2027.
KORU Medical Systems (NASDAQ:KRMD) surpassed revenue expectations in its recent quarterly report, though its stock saw a 14% drop. Analysts maintained their revenue forecasts for 2026 at US$48.1m, an expected 6.6% increase, but modestly raised loss-per-share forecasts to US$0.047. Despite these adjustments, the consensus price target of US$6.60 remains unchanged, indicating analysts believe the company is performing as expected with long-term growth prospects outperforming the industry.
KORU Medical Systems, Inc. (KRMD) published a slide deck in conjunction with their Q2 2026 earnings call. This presentation provides details related to their financial results for the second quarter of 2026. The article was written by SA Transcripts, which is responsible for publishing thousands of quarterly earnings call transcripts.